Ara Chackerian’s Advice for Increasing Your Investment Returns Over Time

Page breadcrumbsEnd of page breadcrumbs

Ara Chackerian is an entrepreneur and investor who is known for his involvement in philanthropy as well. Chackerian received his Bachelor’s of Science degree in marketing from Florida State. Chackerian is currently located in San Francisco, California where he focuses his ventures on improving communities in need and the healthcare field. Chackerian has two decades worth of experience with technology and healthcare, leading to his focus in bridging the two together.

He has co-founded numerous companies, many which are related to healthcare such as BMC Diagnostics, PipelineRx, and TMS Health Solutions. Currently, Ara Chackerian is currently the Managing Director of ASC Capital Holdings, LLC. They invest in healthcare companies during their startup stages where they are searching for innovative ideas to transform America’s healthcare system.

Ara Chackerian is also partners and invests in a variety of non-profit organizations. The non-profit organizations that he seems to focus on are the ones that expand youth educational opportunities to communities that are in need. As it stands, he is now involved in organizations that are involved in the Armenia, Nicaragua, and the United States.

On medium.com, Ara Chackerian has lately talked about how investors should focus on reinvesting their dividend if they want to see their investment yield exponentially increase. He explains that the absence of this strategy can hinder an investor’s return on their investment growth with time.

Since the healthcare sector has shown a great performance in the stock market, Ara Chackerian has provided a few stocks that he believes would be a good investment. He first suggests Welltower, which is a leader in the drug manufacturing industry. Then Abbvie which is another drug manufacturer that has been a leader in the international market. Lastly, he suggests Pfizer which focuses on real estate investment trust, but specifically in the healthcare sector.